Results 81 to 90 of about 730,915 (232)
We describe an adolescent patient presenting with hemoptysis. Detailed clinical work up of the patient showed right ventricular thrombus and bilateral pulmonary artery aneurysms along with the prescribed criteria for the diagnosis of Behcet′s disease ...
Chand Bhandari +3 more
doaj +1 more source
Delphi consensus: First‐line use of biologics and small molecules in hidradenitis suppurativa
This Delphi Consensus study identified upgrade criteria for the use of biologics and small molecules as first‐line therapy in hidradenitis suppurativa (HS). European HS experts evaluated 16 clinical scenarios, voting on eligibility for therapy escalation.
Georgios Nikolakis +54 more
wiley +1 more source
BEHCET'S DISEASE MANAGED WITH ANTI-FUNGAL [PDF]
Purpose: The purpose of this case presentation is to highlight the effectiveness of Diflucan medication in the treatment of Behcet's disease; specifically noting the benefit as a adjunct to typical corticosteroids.
White, Justin
core
PET/CT appearance of intestinal behcet disease [PDF]
Behcet disease is a multisystem, chronic relapsing vasculitis of unknown etiology. Gastrointestinal involvement occurs in 10% to 40%, usually affecting the terminal ileum and cecum.
Anthony, MP, Khong, PL, Zhang, J
core +1 more source
Interleukin-17 in Behçet′s disease: relation with clinical picture and disease activity
Aim The aim of this study was to assess serum levels of interleukin-17 (IL-17) in patients with Behçet′s disease (BD) and to evaluate its relation to the clinical picture and disease activity. Patients and methods This case-control study was carried out
Dina S Al-Zifzaf +2 more
doaj +1 more source
Mehrdad Mohammadpour, Meysam Kosari, Masoud Khorrami-Nejad Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, IranCorrespondence: Mehrdad MohammadpourEye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, IranTel +98 21 5540 0010Email mahammadpour@yahoo.comPurpose: To report a case
Mohammadpour,Mehrdad +2 more
openaire +1 more source
Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II
The majority of bimekizumab‐treated patients shifted from severe to mild and moderate IHS4 stages, and nearly 25% achieved an IHS4 of 0 by Week 48. Bimekizumab led to clinically meaningful improvements across IHS4 outcome measures. These data highlight an opportunity to address the need for effective treatments against draining tunnels.
Thrasyvoulos Tzellos +15 more
wiley +1 more source
Mehrdad Mohammadpour, Meysam Kosari, Masoud Khorrami-Nejad Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, IranCorrespondence: Mehrdad MohammadpourEye Research Center, Farabi Eye Hospital, Tehran University of ...
Mohammadpour M +2 more
doaj
Pulmonary manifestations in a group of patients with Behçet′s disease
Background and aim Behçet′s disease (BD) is a multisystem vasculitis and pulmonary involvement in BD is reported to indicate a poor prognosis and high mortality.
Sherif M Naguib +3 more
doaj +1 more source
Measuring success in HS treatment from the physician's and the patient's perspective
Integrated clinician (HiSCR, IHS4, IHS4‐55, HS‐IGA) and patient (HiSQOL, DLQI) scores, combined with imaging‐based fibrosis and inflammation assessment, redefine treatment success in hidradenitis suppurativa by aligning treat‐to‐target strategies with both inflammatory control and irreversible structural damage.
Georgios Nikolakis +4 more
wiley +1 more source

